It is an absolute honour to receive a Mid-Career Victorian Cancer Agency Fellowship focused on a pan-cancer diagnostic test for the early diagnosis of specific high incidence and low survival cancers.
https://t.co/qIF9LiW8t5
@VicGovDH
Excited to share our recent review entitled "Defining the rules of engagement: B cells, antibodies and cancer control" published in Cellular & Molecular Immunology.
Read it here: https://t.co/u5GK4QRQXf
If you’re aged 45 to 49, you can request your first free kit and join the National Bowel Cancer Screening Program. Over 90% of bowel cancers can be successfully treated if found early. To request at kit, go to https://t.co/f0mrp4jwuk or call 1800 627 701
🫁 Anyone with lungs can get lung cancer!
This #LungCancerAwarenessMonth, we’re breaking stigma and raising awareness about a disease that can affect anyone — not just those with known risk factors.
Early detection and awareness save lives.
#LungHealth#LCAM
If you have a persistent new or changed cough or any chest symptoms, it’s important to see your doctor. This #LungCancerAwarenessMonth, learn the symptoms of #LungCancer https://t.co/LC0pnL6lXM
🚨 PhD candidate Dr Senthuran Shivakumar publishes his first paper with TRACKER:
“Utility of BALF in checkpoint inhibitor pneumonitis evaluation.” 🫁
It reviews BAL in CIP and emerging insights like molecular profiling & the lung microbiome.
🔗https://t.co/vtRL6eaknM
@foochHQ@VicTraffic There is currently an appeal from Victoria police for any witnesses. The report said one person was critically injured.
https://t.co/QFRmCTwAl8
It was an absolute pleasure to present our recent microscopy work at APMC13 in Brisbane yesterday. Thank you to the organisers for the invitation, and a special thank you to @AustralianMMS and the International Federation of Societies for Microscopy for the support. #APMC13
Beyond excited to announce that my team and I have relocated to @MonashSTM. As a new Lab Head, I greatly look forward to this next adventure. Thank you to my wonderful community of colleagues, mentors, collaborators, and friends. Now for the hardest bit, deciding on a Lab name!
In awe of Alice Edy’s visual illustration skills! What a fantastic way of summarising our work presented at Multi-omics. Many thanks to @aruthak and the wonderful organising committee for putting this conference together! Thanks for having me. #multiomics2024@ONJCRI@ONJ_TILs
🥳The fun continues at #multiomics2024! Beautiful talks by the amazing Jessica Duarte Gama (@JessDGDuarte), Fernando Guimaraes (@Fer_NK_nando), Orazio Vittorio (@VittorioOrazio), & Asmerom Sengal (@ATSengal).
It was an absolute pleasure to share some of my team’s work on B cell and Tertiary Lymphoid Structures at Multi-Omics. Thank you @aruthak for the kind invitation and congrats on putting together a fantastic event. #multiomics2024@ONJCRI@ONJ_TILs
👀The first Immuno-Oncology Session coming in hot at #Multiomics2024! Such amazing talks from Anand Jeyasekharan (@adj_23), Tullia Bruno (@BcellBruno), Ram Dasgupta (@DasguptaRam), & Fei Yang (@FeiYang92).
😍It was an honor to chair, alongside the wonderful @JessDGDuarte.
🎨 Thank You for Making Science Meets Art Unforgettable! 🔬
The exhibition was a celebration of innovation and community spirit!
Missed it? You can still view and take home a piece of the exhibition, with proceeds supporting life-saving cancer research: https://t.co/ZFHPQ2wgnj
☀️ National Skin Cancer Action Week
At ONJCRI, Dr. Jessica Duarte and her team are using circulating antibodies as biomarkers to detect melanoma in its earliest stages!
Remember to check your skin regularly—early detection makes all the difference!
Are you coming down to our 2nd symposium today ? We are getting ready to start, opening with our plenary speaker @anna_t_g
Looking forward to a day of amazing science! #MELS2024
This September, we're putting a spotlight on #ProstateCancer, the second-leading cause of cancer death among men in the United States after lung cancer.
Our #TissueTuesday features prostate FFPE tissue, beautifully illustrated through an Opal 6-plex panel (CD4, CD8, CD19, CD21, DC-LAMP, and PNAd) showing Type II #tertiarylymphoidstructures (#TLS). Join us in appreciating this significant work from @JessDGDuarte at @ONJCRI.
Watch Dr. Duarte present the protocol for the in situ interrogation and characterization of TLSs in human and murine tissue sections using Opal-tyramide signal amplification multiplex immunohistochemistry. https://t.co/MMtTu8aVb7
#ProstateCancerAwarenessMonth
Dr. Jessica da Gama Duarte at @ONJCRI uses Sengenics protein microarrays to profile antibodies, gaining key insights into how the immune system recognizes and responds to cancer.
Learn more: https://t.co/DBZUgW127w
#CancerResearch#Biomarkers
🌟 Nothern’s Brightest Stars Student Symposium is back on Oct 25, at La Trobe University! 🌟
Join us from 9am-4pm to see amazing research by students from @ONJCRI, @LIMSLTU, @Austin_Health, @TheFlorey, @MercyHealthAus & @RMIT 🧪
🗓️ Register by Sept 15: https://t.co/jhUAQKc4v8